IL184043A0 - A method for enhancing cardiomyocyte differentiation, cell cultures for use therein and isolated cardiomyocytes produced thereby - Google Patents

A method for enhancing cardiomyocyte differentiation, cell cultures for use therein and isolated cardiomyocytes produced thereby

Info

Publication number
IL184043A0
IL184043A0 IL184043A IL18404307A IL184043A0 IL 184043 A0 IL184043 A0 IL 184043A0 IL 184043 A IL184043 A IL 184043A IL 18404307 A IL18404307 A IL 18404307A IL 184043 A0 IL184043 A0 IL 184043A0
Authority
IL
Israel
Prior art keywords
cell cultures
cardiomyocyte differentiation
isolated cardiomyocytes
cardiomyocytes produced
enhancing cardiomyocyte
Prior art date
Application number
IL184043A
Original Assignee
Es Cell Int Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004907294A external-priority patent/AU2004907294A0/en
Application filed by Es Cell Int Pte Ltd filed Critical Es Cell Int Pte Ltd
Publication of IL184043A0 publication Critical patent/IL184043A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL184043A 2004-12-22 2007-06-19 A method for enhancing cardiomyocyte differentiation, cell cultures for use therein and isolated cardiomyocytes produced thereby IL184043A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2004907294A AU2004907294A0 (en) 2004-12-22 Differentiation of human embryonic stem cells and cardiomyocytes and cardiomyocyte progenitors derived therefrom
PCT/AU2005/001921 WO2006066320A1 (en) 2004-12-22 2005-12-21 Differentiation of human embryonic stem cells and cardiomyocytes and cardiomyocyte progenitors derived therefrom

Publications (1)

Publication Number Publication Date
IL184043A0 true IL184043A0 (en) 2007-10-31

Family

ID=36601256

Family Applications (1)

Application Number Title Priority Date Filing Date
IL184043A IL184043A0 (en) 2004-12-22 2007-06-19 A method for enhancing cardiomyocyte differentiation, cell cultures for use therein and isolated cardiomyocytes produced thereby

Country Status (6)

Country Link
US (1) US20080254003A1 (en)
EP (1) EP1838844A4 (en)
JP (1) JP2008523823A (en)
GB (1) GB2437027A (en)
IL (1) IL184043A0 (en)
WO (1) WO2006066320A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007030870A1 (en) * 2005-09-12 2007-03-22 Es Cell International Pte Ltd Cardiomyocyte production
GB2447191B (en) * 2005-12-22 2011-08-03 Es Cell Int Pte Ltd Direct differentiation of cardiomyocytes from human embryonic stem cells
KR101348325B1 (en) 2006-01-31 2014-01-08 각고호우징 게이오기주크 Method for purifying cardiac myocyte and presumptive cardiac myocyte derived from stem cell and fetus
EP3075850B1 (en) 2008-07-16 2019-02-06 ID Pharma Co., Ltd. Method for production of reprogrammed cell using chromosomally unintegrated virus vector
EP2434007A4 (en) 2009-05-22 2013-07-31 Univ Tokyo Womens Medical Method for inducing differentiation of embryonic stem cells or artificial pluripotent stem cells
KR101772860B1 (en) 2009-06-05 2017-08-30 셀룰러 다이내믹스 인터내셔널, 인코포레이티드 Reprogramming T cells and hematopoietic cells
WO2010144678A2 (en) * 2009-06-10 2010-12-16 The General Hospital Corporation Generation of vascularized human heart tissue and uses thereof
WO2011025852A1 (en) 2009-08-28 2011-03-03 Cellular Dynamics International, Inc. Identifying genetic variation in affected tissues
EP4364797A3 (en) 2009-10-19 2024-07-10 FUJIFILM Cellular Dynamics, Inc. Cardiomyocyte production
WO2011080261A1 (en) 2009-12-28 2011-07-07 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for improved cardiomyogenic differentiation of pluripotent cells
DK2582794T3 (en) 2010-06-15 2018-05-22 Cellular Dynamics Int Inc GENERATION OF INDUCED PLURIPOTENT STEM CELLS FROM SMALL VOLUMES OF PERIPHERAL BLOOD
EP2582792B1 (en) 2010-06-18 2018-10-31 FUJIFILM Cellular Dynamics, Inc. Cardiomyocyte medium with dialyzed serum
US8765470B2 (en) 2010-08-04 2014-07-01 Cellular Dynamics International, Inc. Reprogramming immortalized B-cells to induced pluripotent stem cells
US9181529B2 (en) 2010-10-19 2015-11-10 Cellular Dynamics International, Inc. Titration of differentiation medium components
WO2012135621A2 (en) 2011-03-30 2012-10-04 Cellular Dynamics International. Inc Priming of pluripotent stem cells for neural differentiation
WO2014053709A1 (en) 2012-10-05 2014-04-10 Glykos Finland Oy A method for culturing stem cells
WO2014078414A1 (en) 2012-11-13 2014-05-22 Joseph Wu Chemically defined production of cardiomyocytes from pluripotent stem cells
CN106661553B (en) * 2014-05-06 2020-09-01 豪夫迈·罗氏有限公司 Method for differentiating pluripotent stem cells into cardiomyocytes
CA2957532A1 (en) * 2014-08-07 2016-02-11 Duke University Compositions and methods for the reprogramming of cells into cardiomyocytes
US9765299B2 (en) 2014-09-10 2017-09-19 Wisconsin Alumni Research Foundation Chemically defined albumin-free conditions for cardiomyocyte differentiation of human pluripotent stem cells
CN108463548B (en) 2015-10-30 2023-04-18 加利福尼亚大学董事会 Method for producing T cell from stem cell and immunotherapy method using the T cell

Also Published As

Publication number Publication date
EP1838844A4 (en) 2008-11-26
US20080254003A1 (en) 2008-10-16
JP2008523823A (en) 2008-07-10
GB0714330D0 (en) 2007-09-05
GB2437027A (en) 2007-10-10
WO2006066320A1 (en) 2006-06-29
EP1838844A1 (en) 2007-10-03

Similar Documents

Publication Publication Date Title
IL184043A0 (en) A method for enhancing cardiomyocyte differentiation, cell cultures for use therein and isolated cardiomyocytes produced thereby
EP1660629A4 (en) Automated cell culture system and process
IL181767A0 (en) Scalable process for cultivating undifferential stem cells in suspension
EP1829644A4 (en) Cell production method and cell production facility
GB2411178A8 (en) Apparatus for culturing cells
EP1815244A4 (en) Cell culture device
IL184262A (en) Cell culture method
EP1816683A4 (en) Solar cell and method for producing solar cell
HK1134046A1 (en) Serum preparation apparatus and serum preparation process for cell culture and cell culture process
IL179726A0 (en) A METHOD FOR ENHANCING DIFFERENTIATION OF hES CELLS INTO CARDIOMYOCYTES
GB2404665B (en) Cell culture
GB0522303D0 (en) Culture method
AU2003265094A1 (en) Method for culturing stem cells
PL2298459T3 (en) Method for sorting mail
GB0515585D0 (en) Cell culture carriers,method for manufacturing cell culture carriers and method for culturing cells
EP1829282A4 (en) Method for providing charging attributes
GB0517382D0 (en) Cell culture
EP1806801A4 (en) Fuel cell separator and method for manufacturing the same
IL177405A0 (en) Micro fuel cells and methods for the production thereof
PL1604420T3 (en) Planar fuel cell and method for the production thereof
ZA200506732B (en) Cell culture
GB2416543B (en) Cell culture device and manufacturing method thereof
GB2413564B (en) Cell culture carriers
EP1812582A4 (en) Single protein production in living cells facilitated by a messenger rna interferase
GB0410011D0 (en) Neural cell differentiation method